---
layout: post
title: "Extension of the Period Before the Food and Drug Administration Intends To Begin Enforcing the Statutory 5 Percent Limit on Out-of-State Distribution of Compounded Human Drug Products"
date: 2026-02-05 19:01:13 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-22876
original_published: 2022-10-21 00:00:00 +0000
significance: 8.00
---

# Extension of the Period Before the Food and Drug Administration Intends To Begin Enforcing the Statutory 5 Percent Limit on Out-of-State Distribution of Compounded Human Drug Products

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** October 21, 2022 00:00 UTC
**Document Number:** 2022-22876

## Summary

The Food and Drug Administration (FDA or the Agency) is extending the period before FDA intends to begin enforcing the statutory 5 percent limit on distribution of compounded human drug products out of the State in which they are compounded in States that have not entered into a standard memorandum of understanding (MOU) with FDA addressing certain distributions of compounded human drug products. FDA is extending the period, which was scheduled to end on October 27, 2022, until the effective date of a final rule regarding certain distributions of compounded human drug products and publication of an updated standard MOU.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/10/21/2022-22876/extension-of-the-period-before-the-food-and-drug-administration-intends-to-begin-enforcing-the)
- API: https://www.federalregister.gov/api/v1/documents/2022-22876

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
